Endoscopic management of Barrett’s esophagus: European Society of Gastrointestinal Endoscopy (ESGE) Position Statement
暂无分享,去创建一个
C. Hassan | O. Pech | R. Bisschops | B. Weusten | E. Coron | J. Dumonceau | A. Repici | J. Bergman | M. di Pietro | M. Dinis-Ribeiro | J. Esteban
[1] Irving Waxman,et al. Development and Validation of a Classification System to Identify High-Grade Dysplasia and Esophageal Adenocarcinoma in Barrett's Esophagus Using Narrow-Band Imaging. , 2016, Gastroenterology.
[2] M. Vieth,et al. A randomised trial of endoscopic submucosal dissection versus endoscopic mucosal resection for early Barrett’s neoplasia , 2016, Gut.
[3] G. Ginsberg,et al. Radiofrequency Ablation Is Associated With Decreased Neoplastic Progression in Patients With Barrett's Esophagus and Confirmed Low-Grade Dysplasia. , 2015, Gastroenterology.
[4] M. Rugge,et al. Endoscopic submucosal dissection: European Society of Gastrointestinal Endoscopy (ESGE) Guideline , 2015, Endoscopy.
[5] M. Vieth,et al. The frequency of lymph node metastasis in early-stage adenocarcinoma of the esophagus with incipient submucosal invasion (pT1b sm1) depending on histological risk patterns , 2015, Surgical Endoscopy.
[6] A. Sonnenberg,et al. Length of Barrett's oesophagus and cancer risk: implications from a large sample of patients with early oesophageal adenocarcinoma , 2015, Gut.
[7] E. Steyerberg,et al. Impact of surveillance for Barrett's oesophagus on tumour stage and survival of patients with neoplastic progression , 2015, Gut.
[8] H. Messmann,et al. [S2k guideline: gastroesophageal reflux disease guided by the German Society of Gastroenterology: AWMF register no. 021-013]. , 2014, Zeitschrift fur Gastroenterologie.
[9] W. Schepp,et al. [S2k guideline: gastroesophageal reflux disease guided by the German Society of Gastroenterology: AWMF register no. 021-013]. , 2014, Zeitschrift fur Gastroenterologie.
[10] F. Vleggaar,et al. Surveillance of Barrett's Esophagus and Mortality from Esophageal Adenocarcinoma: A Population-Based Cohort Study , 2014, The American Journal of Gastroenterology.
[11] Jan G P Tijssen,et al. Barrett's oesophagus patients with low-grade dysplasia can be accurately risk-stratified after histological review by an expert pathology panel , 2014, Gut.
[12] J. Tijssen,et al. Radiofrequency ablation vs endoscopic surveillance for patients with Barrett esophagus and low-grade dysplasia: a randomized clinical trial. , 2014, JAMA.
[13] Rebecca C Fitzgerald,et al. British Society of Gastroenterology guidelines on the diagnosis and management of Barrett's oesophagus , 2013, Gut.
[14] C. Hassan,et al. European Society of Gastrointestinal Endoscopy (ESGE) Guideline Development Policy , 2012, Endoscopy.
[15] Jashanpreet Singh,et al. The incidence of oesophageal adenocarcinoma in non-dysplastic Barrett's oesophagus: a meta-analysis , 2011, Gut.